Table 9.11b

Unadjusted Patient Survival, Living Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	887	92.8%	0.9%	887	86.9%	1.1%	313	76.7%	2.4%	139	84.2%	3.1%
Primary Diagnosis	Non-Cholestatic Cirrhosis	438	93.8%	1.1%	438	87.2%	1.6%	105	71.4%	4.4%	10	50.0%	15.8%
	Cholestatic Liver Disease/Cirrhosis	145	96.6%	1.5%	145	93.1%	2.1%	28	89.3%	5.8%	1	100.0%	0.0%
	Acute Hepatic Necrosis	59	86.4%	4.5%	59	76.3%	5.5%	32	65.6%	8.4%	18	83.3%	8.8%
	Biliary Atresia	94	90.4%	3.0%	94	86.2%	3.6%	76	86.8%	3.9%	87	88.5%	3.4%
	Metabolic Diseases	29	93.1%	4.7%	29	82.8%	7.0%	15	93.3%	6.4%	14	85.7%	9.4%
	Malignant Neoplasms	57	91.2%	3.7%	57	84.2%	4.8%	26	53.8%	9.8%	2	100.0%	0.0%
	Other	65	87.7%	4.1%	65	86.2%	4.3%	31	80.6%	7.1%	7	71.4%	17.1%

Source: OPTN/SRTR Data as of August 1, 2003.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2000-2001 for 3 month and 1 year; 1998-1999 for 3 year; and 1996-1997 for 5 year survival.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.